175 related articles for article (PubMed ID: 33505217)
41. Correlation Analysis of Anti-Cardiolipin Antibody/D Dimer/C-Reactive Protein and Coronary Artery Lesions/Multiple-Organ Damage in Children With Kawasaki Disease.
Xu YM; Chu YQ; Wang H
Front Pediatr; 2021; 9():704929. PubMed ID: 34660478
[No Abstract] [Full Text] [Related]
42. Explorative case control study on the associations of serum vitamin D3, folic acid and vitamin B12 levels on Kawasaki disease and coronary artery lesions.
Chen Y; Liu X; Li B; Li J; Meng L; Ye C; Han L; Li H; Deng LL; Su Z; Zhang X
Front Nutr; 2024; 11():1402316. PubMed ID: 38919394
[TBL] [Abstract][Full Text] [Related]
43. Changes in Peripheral Blood Neutrophils, Lymphocytes and IL-10 in Children with Kawasaki Disease from Different Age Groups Undergoing Intravenous Immunoglobulin: A Retrospective Study.
Zhang C; Zhang X; Shen J; Lu X; Zhang J; Chen S
Mediators Inflamm; 2020; 2020():5213451. PubMed ID: 33293897
[TBL] [Abstract][Full Text] [Related]
44. Serum Lp-PLA2 Level Predicting Coronary Artery Lesions in Children with Kawasaki Disease.
Zhang X; Ya-Wang Shao ; Ya-Lan Zhang ; Yi Liu
Heart Surg Forum; 2021 Jul; 24(4):E611-E618. PubMed ID: 34473042
[TBL] [Abstract][Full Text] [Related]
45. High neutrophil : lymphocyte ratio is associated with refractory Kawasaki disease.
Cho HJ; Bak SY; Kim SY; Yoo R; Baek HS; Yang S; Hwang IT; Ban JE
Pediatr Int; 2017 Jun; 59(6):669-674. PubMed ID: 28097746
[TBL] [Abstract][Full Text] [Related]
46. [Values of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in predicting sensitivity to intravenous immunoglobulin in Kawasaki disease].
Yuan YD; Sun J; Li PF; Wei CL; Yu YH
Zhongguo Dang Dai Er Ke Za Zhi; 2017 Apr; 19(4):410-413. PubMed ID: 28407827
[TBL] [Abstract][Full Text] [Related]
47. [Correlation of retinol binding protein 4 with
metabolic indexes of glucose and
lipid, bile cholesterol saturation index].
Wang W; Li N
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2015 Jun; 40(6):657-65. PubMed ID: 26164516
[TBL] [Abstract][Full Text] [Related]
48. S100A12 on circulating endothelial cells surface in children with Kawasaki disease.
Fu S; Gong F; Xie C; Zhu W; Wang W; Shen H; Tang Y
Pediatr Res; 2010 Aug; 68(2):165-8. PubMed ID: 20461025
[TBL] [Abstract][Full Text] [Related]
49. High-Dose Aspirin is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki Disease.
Kuo HC; Lo MH; Hsieh KS; Guo MM; Huang YH
PLoS One; 2015; 10(12):e0144603. PubMed ID: 26658843
[TBL] [Abstract][Full Text] [Related]
50. Acute pericardial effusion representing the TNF-α-mediated severe inflammation but not the coronary artery outcome of Kawasaki disease.
Okada S; Hasegawa S; Suzuki Y; Matsubara T; Shimomura M; Okuda M; Ichiyama T; Ohga S
Scand J Rheumatol; 2015 May; 44(3):247-52. PubMed ID: 25351965
[TBL] [Abstract][Full Text] [Related]
51. Reappraisal of VEGF in the Pathogenesis of Kawasaki Disease.
Chen CY; Huang SH; Chien KJ; Lai TJ; Chang WH; Hsieh KS; Weng KP
Children (Basel); 2022 Sep; 9(9):. PubMed ID: 36138652
[TBL] [Abstract][Full Text] [Related]
52. Serum retinol-binding protein 4 concentration and its ratio to serum retinol are associated with obesity and metabolic syndrome components in children.
Aeberli I; Biebinger R; Lehmann R; L'allemand D; Spinas GA; Zimmermann MB
J Clin Endocrinol Metab; 2007 Nov; 92(11):4359-65. PubMed ID: 17726085
[TBL] [Abstract][Full Text] [Related]
53. Tenascin-C predicts IVIG non-responsiveness and coronary artery lesions in kawasaki disease in a Chinese cohort.
Li Y; Xu Z; Wu L; Liang X; Zhao L; Liu F; Wang F
Front Pediatr; 2022; 10():979026. PubMed ID: 36582508
[TBL] [Abstract][Full Text] [Related]
54. Association between IL-35 and coronary arterial lesions in children with Kawasaki disease.
Su Y; Feng S; Luo L; Liu R; Yi Q
Clin Exp Med; 2019 Feb; 19(1):87-92. PubMed ID: 30054763
[TBL] [Abstract][Full Text] [Related]
55. Association between adipokines and coronary artery lesions in children with Kawasaki Disease.
Kim HJ; Choi EH; Kil HR
J Korean Med Sci; 2014 Oct; 29(10):1385-90. PubMed ID: 25368492
[TBL] [Abstract][Full Text] [Related]
56. Albumin level and progression of coronary artery lesions in Kawasaki disease: A retrospective cohort study.
Xia Y; Qiu H; Wen Z; Shi H; Yu H; Li J; Zhang Q; Wang J; Rong X; Wu R; Chu M
Front Pediatr; 2022; 10():947059. PubMed ID: 36186633
[TBL] [Abstract][Full Text] [Related]
57. Development of coronary artery lesions in indolent Kawasaki disease following initial spontaneous defervescence: a retrospective cohort study.
Takahashi T; Sakakibara H; Morikawa Y; Miura M
Pediatr Rheumatol Online J; 2015 Nov; 13(1):44. PubMed ID: 26530040
[TBL] [Abstract][Full Text] [Related]
58. Predictors of coronary artery lesions after intravenous gamma-globulin treatment in Kawasaki disease.
Mori M; Imagawa T; Yasui K; Kanaya A; Yokota S
J Pediatr; 2000 Aug; 137(2):177-80. PubMed ID: 10931408
[TBL] [Abstract][Full Text] [Related]
59. Persistent monocytosis after intravenous immunoglobulin therapy correlated with the development of coronary artery lesions in patients with Kawasaki disease.
Kuo HC; Wang CL; Liang CD; Yu HR; Chen HH; Wang L; Yang KD
J Microbiol Immunol Infect; 2007 Oct; 40(5):395-400. PubMed ID: 17932598
[TBL] [Abstract][Full Text] [Related]
60. Do cytokines correlate with refractory Kawasaki disease in children?
Wang Y; Qian SY; Yuan Y; Wang Q; Gao L; Chen X; Yu X; Zhen Z
Clin Chim Acta; 2020 Jul; 506():222-227. PubMed ID: 32156603
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
